Grant H. Skrepnek, Ph.D., R.Ph.

Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Education & Experience

Ph.D. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Dissertation: Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry.


2002

M.S. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Thesis: The effect of merger and acquisition activity on shareholder returns in the pharmaceutical industry.


1998

B.S. in Pharmacy Business Management

University of Texas at Austin, Austin, TX

1994


Publications & Presentations

1 2 3 4 > >>
  1. Miller J L, Ernst K, Neely S, Stephens K, Parker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of Opioid Management. 2019
  2. Gilligan A, Alberts D, Roe D, Skrepnek G H. The Financial Toxicity of Cancer Among the Newly-Diagnosed. American Journal of Medicine. 2018
  3. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. Journal of Evaluation in Clinical Practice . 2018
  4. Fox A, Skrepnek G H, Miller J L, Schwier N C, Ripley T L. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. American Journal of Cardiovascular Drugs . 2018
  5. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G H. Career Skills Assessment in a Doctor of Pharmacy Curriculum. American journal of pharmaceutical education. 2018; 82 : 6300
1 2 3 4 > >>



Grants

1 2 >>
  • Sleep Apnea. 2000.
  • Research Fellowship. 2017.
  • Culturally Tailored Smoking Cessation in Lung Cancer Screening (CTSC-LCs) for American Indians: A Randomized Control Trial. 2016.
  • Impact of the Successful Transitions for Engagement Program (STEP), a Pharmacist-Led Transitions of Care Intervention, on Medicaid Hospital Readmissions. 2015.
  • Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. 2017.
1 2 >>